Regulation of ΔNp63α by NFκB

Cell Cycle

Volumn 9, Issue 24, 2010, Pages 4841-4847

  Sen, Tanusree ^a   Chang, Xiaofei ^a   Sidransky, David ^a   Chatterjee, Aditi ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cisplatin; Head and neck cancer; NF B; Ubiquitination; Np63

Indexed keywords

CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN DELTA NP63 ALPHA; PROTEIN P53; PROTEIN P63; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL STRESS; DNA DAMAGE; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 78650334266     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.24.14093     Document Type: Article

References (34)

1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol Cell 1998; 2:305-16.
2. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006; 9:45-56.
3. Benard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 2003; 21:182-91.
4. Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S. Possible oncogenic potential of DeltaNp73: A newly identified isoform of human p73. Cancer Res 2002; 62:636-41.
5. Jost CA, Marin MC, Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997; 389:191-4.
6. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, et al. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is upregulated in human tumors. J Exp Med 2002; 196:765-80.
7. Chatterjee A, Upadhyay S, Chang X, Nagpal JK, Trink B, Sidransky D. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. Cell Cycle 2008; 7:1231-7.
8. Westfall MD, Joyner AS, Barbieri CE, Livingstone M, Pietenpol JA. Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha. Cell Cycle 2005; 4:710-6.
9. Baeuerle PA, Baltimore D. NFkappaB: Ten years after. Cell 1996; 87:13-20.
10. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkappaBalpha: a mechanism for NFkappaB activation. Mol Cell Biol 1993; 13:3301-10.
11. Rothwarf DM, Karin M. The NFkappaB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999; 1999:1.
12. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, et al. Signal-induced site-specific phosphorylation targets IkappaB alpha to the ubiquitinproteasome pathway. Genes Dev 1995; 9:1586-97.
13. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NFkappaB. Nature 1997; 388:548-54.
14. Rothwarf DM, Zandi E, Natoli G, Karin M. IKKgamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395:297-300.
15. Beg AA, Baltimore D. An essential role for NFkappaB in preventing TNFalpha-induced cell death. Science 1996; 274:782-4.
16. Kikuchi H, Ozaki T, Furuya K, Hanamoto T, Nakanishi M, Yamamoto H, et al. NFkappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway. Oncogene 2006; 25:7608-17.
17. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNFalpha-induced apoptosis by NFkappaB. Science 1996; 274:787-9.
18. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NFkappaB. Science 1996; 274:784-7.
19. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NFkappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680-3.
20. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NFkappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004; 6:297-305.
21. Cusack JC Jr, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res 2001; 61:3535-40.
22. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NFkappaB. Nat Med 1999; 5:412-7.
23. Huang Y, Fan W. IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines. Mol Pharmacol 2002; 61:105-13.
24. Wan YY, DeGregori J. The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 2003; 18:331-42.
25. Hellin AC, Calmant P, Gielen J, Bours V, Merville MP. Nuclear factorkappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene 1998; 16:1187-95.
26. Sun X, Shimizu H, Yamamoto K. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 1995; 15:4489-96.
27. Wu H, Lozano G. NFkappaB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994; 269:20067-74.
28. Chatterjee A, Chang X, Sen T, Ravi R, Bedi A, Sidransky D. Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factorkappaB targeting kinase IkappaB kinase beta. Cancer Res 70:1419-29.
29. Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, et al. NFkappaB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 2001; 276:48921-9.
30. Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA, et al. NFkappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem 2000; 275:9501-9.
31. Huang Y, Johnson KR, Norris JS, Fan W. Nuclear factorkappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res 2000; 60:4426-32.
32. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NFkappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999; 274:30353-6.
33. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. Distinct roles of the IkappaB kinase alpha and beta subunits in liberating nuclear factor kappaB (NFkappaB) from IkappaB and in phosphorylating the p65 subunit of NFkappaB. J Biol Chem 2002; 277:3863-9.
34. Chatterjee A, Mambo E, Osada M, Upadhyay S, Sidransky D. The effect of p53-RNAi and p53 knockout on human 8-oxoguanine DNA glycosylase (hOgg1) activity. Faseb J 2006; 20:112-4.